Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantation
Authors:
Open Access
- 28 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (11) , 1525-1534
Abstract
Hepatitis B virus (HBV) reinfection and recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT) are associated with increased graft failure and reduced patient survival. We evaluated the effects of both HCC recurrence and HBV reinfection on the long-term survival of these patients after OLT. One hundred seventy-five patients underwent OLT for HBV-related liver diseases and were the subjects of this retrospective study. We assessed risk factors for HBV reinfection, HCC recurrence, and survival post-OLT using univariate and multivariate analyses. During a mean follow-up of 43.0 ± 42.0 months, 88 of 175 (50.3%) patients transplanted for HBV-related liver disease had HCC prior to OLT. Thirteen (14.8%) of these patients had HCC recurrence after OLT. The mean time for recurrence of HCC was 26.1 ± 31.9 months. Twelve of 175 (6.9%) patients developed HBV reinfection after liver transplantation. The mean time for HBV reinfection was 28.7 ± 26.4 months. Ten of these 12 (83.3%) patients had HCC prior to OLT, and 5 (50%) developed recurrence of HCC. On multivariate analyses, pre-OLT HCC and recurrence of HCC post-OLT were significantly associated with HBV reinfection after transplantation (P = 0.031 and P < 0.001, respectively). HCC recurrence after OLT was associated with lymphovascular invasion (P < 0.001) and post-OLT chemotherapy (P ≤ 0.001). The 3- and 5-year survival rates were significantly decreased in patients with HBV reinfection (P = 0.007) and in patients with HCC recurrence after OLT (P = 0.03). In conclusion, pre-OLT HCC and HCC recurrence after transplantation were associated with HBV reinfection and with decreased patient survival. Hepatitis B immunoglobulin and antiviral therapy was only partially effective in preventing HBV reinfection in patients with HCC recurrence. Liver Transpl 15:1525–1534, 2009. © 2009 AASLD.Keywords
This publication has 27 references indexed in Scilit:
- Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphomaHepatology, 2007
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Recurrence of Hepatitis B is Associated with Cumulative Corticosteroid Dose and Chemotherapy Against Hepatocellular Carcinoma Recurrence After Liver TransplantationLiver Transplantation, 2007
- Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinomaJournal of Hepatology, 2006
- Prophylactic strategies for hepatitis B patients undergoing liver transplant: A cost-effectiveness analysisLiver Transplantation, 2006
- Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosisLiver Transplantation, 2004
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionGastroenterology, 2004
- Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patientsCancer, 2001
- Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative studyHepatology, 1997
- Liver TransplantationNew England Journal of Medicine, 1989